LipoScience lowers proposed range for IPO

Cardiovascular diagnostic company LipoScience Inc. (Raleigh, N.C.) amended its IPO to lower the proposed price range for the offering. The company said it now plans to sell 5 million shares at $9-$10 per share. Earlier this month, LipoScience said it planned to sell the shares at $13-$15. At the $9.50 mid-point of its new range, the company would raise $47.5 million and be valued at $131.9 million. Barclays; UBS; and Piper Jaffray are underwriters. ...